COGNICURRENT

Feb 3 • 05:00 UTC • 🇪🇸 Spain • ABC

The 'miracle pill' against obesity achieves a new victory: it protects the heart

A new study reveals that oral semaglutide, initially designed for diabetes management, shows potential benefits for heart failure patients as well.

#semaglutide #obesity #heart failure #diabetes #cardiology

Read Original Back to Feed

📡 Similar Coverage

🇧🇷 Brazil Feb 2 • 18:12 UTC

Anvisa approves the use of semaglutide for reducing cardiovascular risk

G1 (PT)

🇦🇷 Argentina Feb 5 • 10:01 UTC

How the drugs that will revolutionize obesity treatment work

Clarin (ES)

🇧🇷 Brazil Feb 26 • 16:48 UTC

New oral GLP-1 reduces more glucose and weight than semaglutide in phase 3 study; Orforgliprona increases weight loss by 73%

G1 (PT)

🇧🇷 Brazil Feb 2 • 21:33 UTC

Anvisa approves indication of Ozempic and Wegovy to reduce the risk of heart attack and stroke

Folha (PT)

🇱🇹 Lithuania Feb 18 • 07:53 UTC

Doctor warns: weight loss drugs are only part of a comprehensive treatment

Lrytas

🇬🇧 UK Jan 8 • 06:48 UTC

New alert for everyone taking semaglutide and tirzepatide weight loss jabs

Mirror